Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1623742

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1623742

Clinical Trial Materials And Supplies Market Size, Share, Growth Analysis, By Service (Logistics & Distribution, Storage & Retention), By Phase (Phase I, Phase II), By Type, By Therapeutic Area, By Region - Industry Forecast 2025-2032

PUBLISHED:
PAGES: 260 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Clinical Trial Materials And Supplies Market size was valued at USD 3.5 billion in 2023 and is poised to grow from USD 3.84 billion in 2024 to USD 8.12 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

The management of clinical trial supplies is critical to avert issues such as inventory expiration and overproduction, especially as drug detection costs rise. Effective supply chain management is essential in clinical research, addressing infrastructure limitations and stringent regulations. Key market drivers include the expansion and growing complexity of clinical trials. Clinical trial supplies encompass various instruments like infusion pumps, nebulizers, and syringe needles, pivotal for evaluating and treating diseases across cardiovascular, neurological, oncological, and pulmonary fields. Outsourcing of supplies by drug developers and manufacturers is increasing, ensuring timely delivery to investigator sites. Additionally, technological advancements, strategic growth among solution providers, and a rise in patent expirations have fueled demand for clinical trial materials, contributing to robust market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Materials And Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Materials And Supplies Market Segmental Analysis

Global Clinical Trial Materials And Supplies Market is segmented by service, phase, type, therapeutic area, end user and region. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labelling & blinding, manufacturing, comparator sourcing and other services. Based on phase, the market is segmented into Phase I, Phase II, Phase III, Phase IV, BA/BE Studies. Based on type, the market is segmented into small-molecules, biologic drugs and medical devices. Based on therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases and other therapeutic areas. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organisations (CRO's) and medical device companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is significantly driven by the increasing participation of patients in clinical trials within emerging economies such as China, India, and South Korea. The lower costs associated with conducting clinical trials in these nations-28% cheaper before tax incentives and a remarkable 60% less expensive after tax incentives compared to the United States-have attracted pharmaceutical companies seeking to optimize their research expenditures. This trend has also led to a shift in clinical trial locations, particularly for rare diseases. Furthermore, advancements in technology and data analytics contribute to improved decision-making in clinical trials, prompting the pharma and biotech sectors to invest in outsourcing innovative solutions that enhance trial processes and supply chains in these developing markets.

Restraints in the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market faces considerable restraints primarily due to the high attrition rates of drug candidates during development, which lead to immense research and development costs. The complexities associated with R&D for rare diseases often require specialized personnel to conduct clinical trials, further complicating the process. For instance, only 7 out of 100 cancer drugs that reach clinical trials ultimately gain regulatory approval, with most drug candidates failing before this stage. Additionally, the entire journey from drug discovery to FDA approval can span 10-15 years and incur costs around USD 2.6 billion, with less than 12% of candidates reaching Phase clinical trials successfully, posing significant challenges to market expansion.

Market Trends of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is witnessing a notable trend towards the increased utilization of biologics and temperature-sensitive medications, with approximately 35% of late-phase pharmaceutical drugs classified as biologics, alongside 38% being temperature-sensitive. This shift is largely attributed to the advantages biologics offer, including fewer side effects compared to traditional pharmaceuticals. With the expectation that the prevalence of biologics will continue to rise, there is a corresponding surge in demand for advanced cold chain logistics and storage solutions to ensure the efficacy and safety of these sensitive materials during clinical trials, thereby shaping the future landscape of the market.

Product Code: SQMIG35B2074

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Technology Analysis
  • Regulatory Analysis

Global Clinical Trial Materials And Supplies Market Size by Service & CAGR (2025-2032)

  • Market Overview
  • Logistics & Distribution
  • Storage & Retention
  • Packaging, Labelling & Blinding
  • Manufacturing
  • Comparator Sourcing
  • Other Services

Global Clinical Trial Materials And Supplies Market Size by Phase & CAGR (2025-2032)

  • Market Overview
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • BA/BE Studies

Global Clinical Trial Materials And Supplies Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Small-Molecules
  • Biologic Drugs
  • Medical Devices

Global Clinical Trial Materials And Supplies Market Size by Therapeutic Area & CAGR (2025-2032)

  • Market Overview
  • Oncology
  • Infectious Diseases
  • Neurology
  • Metabolic Disorders
  • Immunology
  • Cardiology
  • Genetic Diseases
  • Other Therapeutic Areas

Global Clinical Trial Materials And Supplies Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organisations (CRO's)
  • Medical Device Companies

Global Clinical Trial Materials And Supplies Market Size & CAGR (2025-2032)

  • North America (Service, Phase, Type, Therapeutic Area, End User)
    • US
    • Canada
  • Europe (Service, Phase, Type, Therapeutic Area, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Service, Phase, Type, Therapeutic Area, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Service, Phase, Type, Therapeutic Area, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Service, Phase, Type, Therapeutic Area, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Lonza Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Catalent, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Piramal Pharma Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Almac Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Parexel International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Marken (A Subsidiary of UPS)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sharp Services, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PCI Pharma Services
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nuvisan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celerion
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WuXi AppTec
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Recipharm AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tunnell Consulting
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aesica Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kendle International (Now a part of INC Research)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syneos Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vetter Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!